127 related articles for article (PubMed ID: 10583435)
1. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules.
Van Baal WM; Emeis JJ; Kenemans P; Kessel H; Peters-Muller ER; Schalkwijk CG; van der Mooren MJ; Stehouwer CD
Eur J Clin Invest; 1999 Nov; 29(11):913-21. PubMed ID: 10583435
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women.
van Baal WM; Kenemans P; Emeis JJ; Schalkwijk CG; Mijatovic V; van der Mooren MJ; Vischer UM; Stehouwer CD
Fertil Steril; 1999 Apr; 71(4):663-70. PubMed ID: 10202876
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on blood platelets.
Thijs A; van Baal WM; van der Mooren MJ; Kenemans P; Dräger AM; Huijgens PC; Stehouwer CD
Eur J Clin Invest; 2002 Aug; 32(8):613-8. PubMed ID: 12190961
[TBL] [Abstract][Full Text] [Related]
5. Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal women.
Post MS; Hendriks DF; Van Der Mooren MJ; Van Baal WM; Leurs JR; Emeis JJ; Kenemans P; Stehouwer CD
J Intern Med; 2002 Mar; 251(3):245-51. PubMed ID: 11886484
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
7. Effects of soy isoflavones on endothelial function in healthy postmenopausal women.
Colacurci N; Chiàntera A; Fornaro F; de Novellis V; Manzella D; Arciello A; Chiàntera V; Improta L; Paolisso G
Menopause; 2005; 12(3):299-307. PubMed ID: 15879919
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
9. Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal women.
Post MS; Rosing J; Van Der Mooren MJ; Zweegman S; Van Baal WM; Kenemans P; Stehouwer CD;
Br J Haematol; 2002 Dec; 119(4):1017-23. PubMed ID: 12472583
[TBL] [Abstract][Full Text] [Related]
10. No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women.
Hemelaar M; Kenemans P; Schalkwijk CG; Braat DD; van der Mooren MJ
Hum Reprod; 2006 Jun; 21(6):1635-42. PubMed ID: 16501036
[TBL] [Abstract][Full Text] [Related]
11. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations.
Miles EA; Thies F; Wallace FA; Powell JR; Hurst TL; Newsholme EA; Calder PC
Clin Sci (Lond); 2001 Jan; 100(1):91-100. PubMed ID: 11115423
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of serum levels of adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) in stable and unstable angina and acute myocardial infarction].
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Przegl Lek; 2003; 60(7):445-50. PubMed ID: 14750416
[TBL] [Abstract][Full Text] [Related]
13. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
[TBL] [Abstract][Full Text] [Related]
15. Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women.
Goudev A; Georgiev DB; Koycheva N; Manasiev N; Kyurkchiev S
Maturitas; 2002 Sep; 43(1):49-53. PubMed ID: 12270582
[TBL] [Abstract][Full Text] [Related]
16. Plasma sICAM levels during standard exercise test are higher in postmenopausal women with mixed hyperlipemia. sICAM level in postmenopausal women.
Ociepka A; Milewicz T; Krzyczkowska-Sendra-Kowska M; Stochmal E; Fedak D
Przegl Lek; 2016; 73(7):448-51. PubMed ID: 29676885
[TBL] [Abstract][Full Text] [Related]
17. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women.
Koh KK; Jin DK; Yang SH; Lee SK; Hwang HY; Kang MH; Kim W; Kim DS; Choi IS; Shin EK
Circulation; 2001 Apr; 103(15):1961-6. PubMed ID: 11306524
[TBL] [Abstract][Full Text] [Related]
18. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
19. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
[TBL] [Abstract][Full Text] [Related]
20. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
